The review discusses fifty eight peptides in various clinical phases, indicating a strong pipeline of peptide therapies focusing on PPIs. By way of example, latest studies have highlighted the efficacy of peptide therapies in taking care of autoimmune disorders, with clients going through less Uncomfortable side effects compared to traditional t